Can a nitroglycerin (glyceryl trinitrate) patch be used to treat hypertensive urgency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitroglycerin Patch for Hypertensive Urgency

Nitroglycerin patches are not recommended for hypertensive urgency as they are not among the preferred agents for this condition according to current guidelines. 1, 2

Definition and Appropriate Management of Hypertensive Urgency

  • Hypertensive urgency is defined as severe blood pressure elevation (typically systolic BP >180 mmHg or diastolic BP >120 mmHg) without evidence of acute end-organ damage 2, 3
  • Unlike hypertensive emergencies, hypertensive urgencies do not require immediate blood pressure reduction with intravenous medications 1
  • Oral antihypertensive agents are the preferred treatment for hypertensive urgency, allowing for a more gradual reduction in blood pressure 2, 3

Role of Nitroglycerin in Hypertension Management

  • Nitroglycerin is primarily indicated for specific conditions with hypertension, including:

    • Acute pulmonary edema with hypertension 1
    • Acute coronary syndromes with hypertension 1
    • Hypertension with angina not responsive to sublingual nitroglycerin 4
  • Intravenous nitroglycerin (not patches) may be used in these specific scenarios, but even then:

    • It is not a first-line agent for pure hypertensive urgency 5, 6
    • The American College of Cardiology/American Heart Association guidelines do not recommend nitroglycerin to reduce events but only to relieve ischemic pain, acute hypertension with specific cardiac indications, or to manage pulmonary congestion 1

Limitations of Nitroglycerin Patches for Hypertensive Urgency

  • Nitroglycerin patches have several limitations for hypertensive urgency:
    • Slow onset of action and unpredictable blood pressure response 2, 3
    • Tachyphylaxis (tolerance) develops rapidly, often within 24 hours 4
    • Cannot be easily titrated compared to intravenous formulations 7
    • Potential for excessive blood pressure reduction, which can compromise organ perfusion 1

Preferred Agents for Hypertensive Urgency

  • Oral agents recommended for hypertensive urgency include:

    • Labetalol 1
    • Captopril 6
    • Clonidine 6
    • Oral calcium channel blockers 1
  • For hypertensive emergencies (with end-organ damage), intravenous agents are preferred:

    • Clevidipine 5
    • Nicardipine 1
    • Labetalol 1
    • Esmolol (especially with aortic dissection) 1
    • Fenoldopam 1

Important Considerations in Blood Pressure Reduction

  • The goal in hypertensive urgency is gradual blood pressure reduction over 24-48 hours 3
  • Excessive or rapid blood pressure reduction can lead to organ hypoperfusion and ischemia 8
  • The European Society of Cardiology recommends a mean arterial pressure reduction of only 20-25% over several hours 8
  • Blood pressure should be monitored closely during treatment 4

Conclusion

Nitroglycerin patches are not appropriate for the management of hypertensive urgency. They are slow-acting, difficult to titrate, and not recommended by current guidelines for this indication. Oral antihypertensive agents are the preferred treatment for hypertensive urgency, while intravenous agents are reserved for hypertensive emergencies with end-organ damage.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The diagnosis and treatment of hypertensive crises.

Postgraduate medicine, 2009

Guideline

Role of Intravenous Nitroglycerin in Resistant Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug therapy of hypertensive crises.

Clinical pharmacy, 1988

Research

Intravenous therapy for hypertensive emergencies, part 1.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009

Guideline

Management of Nitroprusside Infusion in Hypertensive Emergency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.